Stock 6493 TTBIO CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ttbio Corp.

Equities

6493

TW0006493000

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-21 EDT 		5-day change 1st Jan Change
20.8 TWD +2.46% Intraday chart for Ttbio Corp. +4.26% -4.81%
04-17 Ttbio Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Ttbio Corp. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 714.3 716.7 523.1 536.3 650.6 525.5
Enterprise Value (EV) 1 691.5 724 558.7 542.1 663.2 610.7
P/E ratio 16.3 x 18.9 x 11.4 x 46.5 x 16.4 x 78.7 x
Yield 5.05% 5.03% 9.2% 2.24% 4.62% 1.37%
Capitalization / Revenue 2.62 x 2.69 x 2.92 x 1.76 x 1.55 x 1.65 x
EV / Revenue 2.54 x 2.72 x 3.12 x 1.77 x 1.58 x 1.92 x
EV / EBITDA 11.6 x 13.3 x 39.1 x 13.7 x 9.86 x 20.1 x
EV / FCF -22.3 x 22.2 x -22.8 x 19.2 x -36.5 x -12.9 x
FCF Yield -4.48% 4.51% -4.39% 5.2% -2.74% -7.78%
Price to Book 2.23 x 2.23 x 1.83 x 1.82 x 2.01 x 1.75 x
Nbr of stocks (in thousands) 24,050 24,050 24,050 24,050 24,050 24,050
Reference price 2 29.70 29.80 21.75 22.30 27.05 21.85
Announcement Date 4/17/19 4/15/20 4/26/21 4/12/22 4/18/23 4/17/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 272.3 266.6 179 305.5 418.9 318.1
EBITDA 1 59.84 54.29 14.27 39.64 67.28 30.36
EBIT 1 32.54 24.46 -13.72 12.26 38.36 -0.862
Operating Margin 11.95% 9.18% -7.67% 4.01% 9.16% -0.27%
Earnings before Tax (EBT) 1 42.27 34.42 46.01 14.12 48.31 8.089
Net income 1 43.85 37.99 45.88 11.53 39.8 6.677
Net margin 16.11% 14.25% 25.64% 3.77% 9.5% 2.1%
EPS 2 1.820 1.580 1.900 0.4795 1.650 0.2776
Free Cash Flow 1 -31.01 32.64 -24.54 28.21 -18.16 -47.51
FCF margin -11.39% 12.24% -13.71% 9.23% -4.34% -14.94%
FCF Conversion (EBITDA) - 60.12% - 71.17% - -
FCF Conversion (Net income) - 85.91% - 244.63% - -
Dividend per Share 2 1.500 1.500 2.000 0.5000 1.250 0.3000
Announcement Date 4/17/19 4/15/20 4/26/21 4/12/22 4/18/23 4/17/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 7.34 35.7 5.81 12.6 85.3
Net Cash position 1 22.7 - - - - -
Leverage (Debt/EBITDA) - 0.1353 x 2.499 x 0.1465 x 0.1879 x 2.808 x
Free Cash Flow 1 -31 32.6 -24.5 28.2 -18.2 -47.5
ROE (net income / shareholders' equity) 14.2% 11.8% 15.1% 3.97% 12.9% 2.14%
ROA (Net income/ Total Assets) 4.84% 3.4% -1.95% 1.75% 4.84% -0.1%
Assets 1 905.7 1,118 -2,352 658.1 822.8 -6,439
Book Value Per Share 2 13.30 13.40 11.90 12.30 13.40 12.50
Cash Flow per Share 2 3.070 3.340 1.750 2.910 4.700 2.470
Capex 1 44.4 27.5 9.78 14.8 36.6 41.9
Capex / Sales 16.32% 10.31% 5.47% 4.83% 8.74% 13.16%
Announcement Date 4/17/19 4/15/20 4/26/21 4/12/22 4/18/23 4/17/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Supplies

1st Jan change Capi.
TTBIO CORP. Stock Ttbio Corp.
-4.81% 15.49M
COLOPLAST A/S Stock Coloplast A/S
+11.89% 28.61B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-32.33% 3.02B
HARTALEGA HOLDINGS Stock Hartalega Holdings
+32.96% 2.61B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-17.26% 2.49B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+4.75% 2.19B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
+32.22% 2.03B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-6.23% 1.98B
GVS S.P.A. Stock GVS S.p.A.
+26.82% 1.33B
KOSSAN RUBBER INDUSTRIES Stock Kossan Rubber Industries
+31.89% 1.33B
Medical Supplies
  1. Stock Market
  2. Equities
  3. 6493 Stock
  4. Financials Ttbio Corp.